Mutations in TRAF3IP1/IFT54 reveal a new role for IFT proteins in microtubule stabilization

Albane A. Bizet(Délégation Paris 5), Sophie Saunier(Hôpital Necker-Enfants Malades), Bolan Linghu(AstraZeneca (United Kingdom)), Rebecca Ryan(Université Paris Cité), Meriem Garfa‐Traoré(Délégation Paris 5), Esben Lorentzen(Aarhus University), Jan Halbritter(Humboldt-Universität zu Berlin), Neveen A. Soliman(Cairo University), Pauline Krug(Délégation Paris 5), Mohammed Zarhrate(Délégation Paris 5), Anita Becker-Heck(Novartis (Switzerland)), Edward J. Oakeley(Novartis (Switzerland)), Patrick Nitschké(Délégation Paris 5), Marie-Christine Lasbennes(Novartis (Switzerland)), Philippe Dubot(Avalon Pharma (United States)), Élisabeth Cassuto(Hôpital l'Archet), Rémi Salomon(Inserm), Andreas W. Sailer(Novartis (Switzerland)), José‐Alain Sahel(University of Pittsburgh), Corinne Antignac(Hôpital Necker-Enfants Malades), Marie-Claire Gübler(Inserm), Tewis Bouwmeester(Institute of Pathology Celle), Fabrizio C. Serluca(Novartis (United States)), Friedhelm Hildebrandt(Boston Children's Hospital), Alexandre Benmerah(Inserm), Iain A. Drummond(Mount Desert Island Biological Laboratory), Pierre Saint-Mézard(Novartis (Switzerland)), Emilie Filhol(Délégation Paris 5), Fan Yang(Beijing Tongren Hospital), Lucile Pinson(Université de Montpellier), Salah‐Dine Chibout(Novartis (Switzerland)), Marion Delous(Université Claude Bernard Lyon 1), Kristina Weber(Max Planck Institute of Biochemistry), Joseph D. Szustakowski(Novartis (United States))
Nature Communications
October 21, 2015
Cited by 105


Related Papers